ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - charcoal activated; simethicone - קפסולות - simethicone 45 mg; charcoal activated 140 mg - medicinal charcoal, combinations - medicinal charcoal, combinations - anti-flatulent, for symptomatic treatment of stomach ache resulting from accumulation of gas, relief of sensation of fullness, meteorism, bloating and flatulence.

ישראל - עברית - Ministry of Health

hirshberg brothers & co. - charcoal activated - טבליה - charcoal activated 125 mg - medicinal charcoal - medicinal charcoal - adsorption of intestinal gas as an aid in the treatment of diarrhea

ישראל - עברית - Ministry of Health

trupharm marketing 1985 ltd. - medicinal charcoal; rhubarb; sennae folium; sulfur purified - טבליה - sennae folium 105 mg; rhubarb 25 mg; sulfur purified 50 mg; medicinal charcoal 180 mg - medicinal charcoal, combinations - medicinal charcoal, combinations - mild laxative, anti-flatulant.

ישראל - עברית - Ministry of Health

genmedix - activated charcoal 0.2 g/ml - suspension - charcoal preparations - emergency antidote in treatment of poisoning by most drugs and chemicals.

ישראל - עברית - Ministry of Health

cure medical & technical supply - sodium chloride; starch etherified - תמיסה לאינפוזיה - starch etherified 60 g/l; sodium chloride 9 g/l - blood substitutes and plasma protein fractions - therapy and prophylaxis of hypovolemia, acute normovolaemic haemodilution technique.

ישראל - עברית - Ministry of Health

novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 200 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ישראל - עברית - Ministry of Health

novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 400 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ישראל - עברית - Ministry of Health

novartis israel ltd - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 100 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l

ישראל - עברית - Ministry of Health

novartis israel ltd - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 400 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 100 mg - imatinib